-

Thermo Fisher Scientific Introduces Ambient Shipping Solution for its Invitrogen™ Antibodies to Help Customers Reduce Packaging Waste and Carbon Emissions

New ambient temperature packaging represents a 90% reduction in shipment packaging mass

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced more sustainable packaging for 125,000 of its Invitrogen™ antibodies. Transitioning from cold-chain packaging to ambient temperature shipping from distribution center to customer reduces package material mass, improves the customer experience and supports the company’s global sustainability efforts.

Through functional and stability testing, Thermo Fisher has demonstrated that a significant portion of its Invitrogen antibody portfolio can be maintained at ambient temperature conditions during transport. By eliminating the use of cold gel packs and introducing a new 100% curbside recyclable paper packaging for customers, Thermo Fisher expects to eliminate more than 216,000 pounds of paper and 440,000 pounds of gel ice packs per year. This new packaging represents a 90% reduction in shipment mass, improves freight density and reduces carbon emissions.

"Our ambient shipping initiative is a response to our customers' expectations and demonstrates our commitment to sustainability and innovation," said Ellie Mahjubi, vice president, protein cell analysis, Thermo Fisher Scientific. "We are proud to launch this critical change, delivering on Thermo Fisher's Mission to enable our customers to make the world healthier, cleaner and safer. We believe this transition will have a considerable impact on the global research community by reducing packaging waste and transport emissions without compromising the quality of our antibodies."

"Antibodies are important to our work in genetics and genomics," said Graham Erwin, assistant professor, molecular and human genetics, Baylor College of Medicine. "This more sustainable shipping solution helps simplify our laboratory's operations by reducing packaging waste and minimizing our environmental impact without compromising on our research goals."

A Sustainable Evolution of Packaging

The introduction of ambient shipping and Sustainable Forestry Initiative-certified packaging marks the latest advancements in Thermo Fisher’s commitment to more sustainable shipping. Thermo Fisher also ships many temperature sensitive products in a paper cooler as a more sustainable alternative to other coolers for products that still require shipping at low temperatures.

For more information on greener shipping, please visit the Thermo Fisher thermofisher.com/abambientshipping.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Name: Kristin Blake
Phone: 760-637-1166
E-mail: kristin.blake@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Name: Kristin Blake
Phone: 760-637-1166
E-mail: kristin.blake@thermofisher.com

More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom